Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-04-013721
Filing Date
2004-02-03
Accepted
2004-02-03 16:08:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS d424b5.htm 424B5 500076
3 GRAPHIC g97290g18u00.jpg GRAPHIC 17928
4 GRAPHIC g97290g40c29.jpg GRAPHIC 49118
  Complete submission text file 0001193125-04-013721.txt   568803
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-104832 | Film No.: 04563164
SIC: 2836 Biological Products, (No Diagnostic Substances)